Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000557160 | SCV000651870 | likely benign | BAP1-related tumor predisposition syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000565170 | SCV000672735 | likely benign | Hereditary cancer-predisposing syndrome | 2017-05-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000565170 | SCV000687971 | likely benign | Hereditary cancer-predisposing syndrome | 2016-06-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001584322 | SCV001820958 | likely benign | not provided | 2021-05-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000565170 | SCV002537270 | benign | Hereditary cancer-predisposing syndrome | 2021-11-19 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV002268159 | SCV002550687 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003900221 | SCV004714126 | likely benign | BAP1-related condition | 2021-12-30 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |